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Renal ischemia/reperfusion injury contributes to renal damage in
experimental anti-niyeloperoxidase-associated proliferative glomerulone.
phritis. The occurrence of focal fibrinoid necrosis of capillary loops in the
very early stages of ANCA-associated necrotizing crescentic glomerulo-
nephritis (NCGN) and the increased prevalence of this disease at older
age suggest that renal ischemia may play an additional role in its
pathophysiology. In the present study we investigated the contribution of
renal ischemia to the induction of anti-myeloperoxidase (MPO) associated
NCGN in a previously described rat model of this disease. The develop-
ment of renal lesions is dependent on the presence of an anti-MPO
immune response and the localization of a lysosomal extract containing
lyric enzymes and MPO in combination with hydrogen peroxide (H202)
along the glomerular basement membrane (GBM). The hypothesis tested
whether perfusion of hydrogen peroxide (H202) could be replaced by
ischemia/reperfusion (I/R) injury, as hR injury activates endothelial cells
to produce oxygen metabolites. hR was induced by clamping the renal
artery for 20 minutes in kidneys in which the circulation had been restored
several minutes after perfusion with the lysosomal extract in MPO
immunized rats. Rats developed lesions characterized by intra- and
extracapillaiy cell proliferation, periglomerular infiltration, ruptures in
Bowman's capsule, ischemic tubuli, and interstitial mononuclear infiltrate.
Immune deposits, however, persisted for a longer time along the GBM
after perfusion of lytic enzymes followed by hR injury compared to
previous studies in which H202 in conjunction with lytic enzymes were
perfused in MPO-immunized rats. Control groups consisting of control
immunized rats perfused with the lysosomal extract followed by hR and
MPO immunized rats perfused with the lysosomal extract developed
minor lesions only. To further explore the possible mechanisms involved
in the contribution of hR to the development of NCGN, we studied the
expression of ICAM-1 in renal tissue from the three experimental groups.
Up-regulation of ICAM-1 occurred in MPO-immunized rats perfused
with the lysosomal extract followed by hR and also in both control groups,
suggesting that up-regulation of ICAM-1 in itself is not sufficient to induce
lesions. In conclusion, renal ischemia contributes to the development of
experimental anti-MPO associated NCGN possibly by inducing endothe-
hal cells to produce toxic oxygen metabolites.
Necrotizing crescentic glomerulonephritis (NCGN) clinically
manifest as rapidly progressive glomerulonephritis, may be asso-
ciated with multisystem disorders from infectious or non-infec-
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tious origin, or may occur in patients without a systemic illness [1].
NCGN can be classified into three immunopathogenic categories:
(i) anti-glomerular basement membrane (GBM) antibody medi-
ated, (ii) immune complex mediated, and (iii) anti-neutrophil
cytoplasmic antibody (ANCA) associated [2}. ANCA in patients
with ANCA associated NCGN are, generally, either directed to
proteinase 3 (Pr3) [3—5] or myeloperoxidase (MPO) [2, 6, 7], both
myeloid lysosomal enzymes. The initial lesion in this form of
NCGN is characterized by segmental fibrinoid necrosis of the
glomerular basement membrane (GBM) followed by marked
infiltration of neutrophils and mononuclear cells, and paucity of
IgG deposits [8—12]. Focal fibrinoid necrosis of capillary loops is
present at a very early stage in the development of NCGN,
indicating that focal endothelial damage and GBM necrosis,
possibly aggravated by ischemia, are prerequisites for the devel-
opment of ANCA-associated NCGN. Ischemia followed by reper-
fusion (h/R) is known to induce endothelial cell damage as well as
leukocyte accumulation in reperfused organs. Renal hR injury is
characterized by reduced renal blood flow, increased vascular
resistance, decreased glomerular filtration rate, erythrocyte trap-
ping, and tubular obstruction proportional to the duration of the
ischemic insult [13]. Activation of endothelial cells in reperfused
organs is characterized by elevated intracellular calcium levels,
production of platelet activating factor, nitric oxide (NO), and
superoxide (O2) production, and up-regulation of adhesion
molecules like selectins and intercellular adhesion molecule-i
(ICAM-1) [14—19]. Evidence has accumulated that neutrophils
play a pivotal role in renal reperfusion injury by the production of
oxygen radicals and release of lysosomal enzymes [13, 20]. Several
recent studies on limb hR associated lung injury and myocardial
hR injury have demonstrated that blocking of ICAM-1 on endo-
thelial cells and/or f32-integrins on neutrophils attenuates reper-
fusion injury [17, 21]. No studies so far have been performed on
the role of adhesion molecules in renal hR. In a recently
developed model of anti-MPO associated NCGN, characterized
by glomerular intracapillary thrombosis followed by a proliferative
glomerulonephritis, we demonstrated that anti-MPO alone is not
sufficient for the induction of NCGN but that MPO, lytic enzymes,
and hydrogen peroxide need to be localized along the GBM [22}.
in view of the focal fibrinoid necrosis of capillary loops in human
ANCA associated NCGN [23, 24], in which focal ischemia may
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play an additive role, and the need for oxygen radicals in the
experimental model for anti-MPO associated NCGN, we tested
whether ischemia could play a role in the induction of experimen-
tal NCGN. Ischemia was induced in MPO immunized rats,
directly after unilateral renal perfusion with a lysosomal extract
containing MPO, HLE, and Pr3, without hydrogen peroxide, by
clamping the left renal artery for 20 minutes starting after the
circulation had been reconstituted for several minutes. In addi-
tion, since adhesion molecules have been shown to play an
important role in limb hR associated lung injury and myocardial
I/R, we also investigated the presence and up-regulation of
adhesion molecules in relation to renal hR.
Methods
Rats
All experiments were performed on conventionally housed,
three month old Brown-Norway (BN) rats obtained from Harlan,
Bilthoven, The Netherlands, fed ad libitum with standard chow
(Hope Farms, Woerden, The Netherlands).
Lysosomal enzyme extract
Human polymorphonuclear leukocytes (PMN) were isolated
from buffy coats on a ficoll density gradient followed by dextran
sedimentation. After sedimentation the remaining erythrocytes
were removed by hypotonic lysis. MPO was extracted from PMN
by dissolution of the cells in cetyltrimethyl ammonium bromide
(CETAB) and sonification. Nuclei and membrane fragments were
discarded by ultracentrifugation and the extract was absorbed to a
concanavalin A sepharose gel and eluted with a-methyl-D-man-
noside. Eluted fractions with a ratio (OD 428/280) greater than
0.5, measured as the ratio between the optical density (OD)
obtained at 428 nm (showing a specific spectral band for MPO)
and the OD obtained at 280 nm, were pooled and extensively
dialyzed to sodium-acetate buffer pH 6.0 [25]. The resulting
lysosomal extract had an OD 428/280 ratio greater than 0.5 and
contained mainly MPO, proteinase 3, and trace amounts of
elastase, but no lactoferrin as determined by sandwich ELISA [3].
In accordance with the results of ELISA specific bands for MPO
(at 15, 39 and 58 kD) and Pr3 (at 30 kD) were found by gel
electrophoresis (results not shown). Peroxidase activity of the
extract was assayed spectrophotometrically by measuring the
increase in absorbance at 470 nm upon oxidation of guaiacol
(Sigma Chemical Co, St. Louis, MO, USA). In brief, 10 d of the
MPO preparation was added to a 1-cm light path cuvette contain-
ing 3 ml of the assay solution. The solution consisted of 29.6 ml
H2O, 3 ml 0.1 M sodium phosphate buffer, pH 7.0, 0.1 ml 0.1 M
H202, and 48 d guaiacol. One unit (U) of peroxidase activity is
defined as the amount that consumes 1 mol of H202 per minute
[26]. One hundred micrograms of the lysosomal extract contained
approximately 78 g MPO with an activity of 30 U.
Myeloperoxidase
For immunization MPO was further purified from the lysoso-
mal extract on a sephadex G150 gel (Pharmacia, Fine Chemicals
AB, Uppsala, Sweden). Fractions with an OD 428/280 ratio
greater than 0.8 were pooled. Contamination with Pr3 or HLE
was ruled out by antigen specific ELISA for Pr3 and HLE.
Immunization procedure
BN rats were immunized with human MPO in Complete
Freunds Adjuvant (CFA) supplemented with H37Ra, 5mg/mi
(Difco, Detroit, MI, USA). Rats received 10 g MPO or control
solution without MPO (= sodium-acetate buffer) subcutaneously
(s.c.) in 0.2 ml at two sites near the tailbase.
Detection of anti-MPO antibodies by ELISA
Labstar (Greiner, Kremsmünster, Austria) microtiter plates
were coated overnight with human MPO (isolated as described
before) at a protein concentration of 20 pg/ml in 0.1 M carbonate
buffer, pH 9.6. The plates were incubated with rat plasma, diluted
in 0.05 M Tris, 0.05% Tween, 2% BSA, and 0,3 M NaCl, pH 8.0,
starting at a dilution of 1:100 in PBS. Antibody binding was
detected with sheep anti-rat Ig conjugated to alkaline phosphatase
(Serotec, Oxford, UK), followed by p-nitrophenyl phosphate
disodium as a substrate. The OD was read at 405 nm, and a
standard curve was prepared from a reference serum. Antibody
concentrations were computed from the linearized titration curve
obtained after log-logit transformation of the absorbances of the
respective dilutions of the reference serum. The concentration of
the reference serum was set at 100 U.
Renal perfusion
Unilateral perfusion of the left kidney was performed according
to a modification of the method of Hoyer, Mauer, and Michael
[27]. Rats were anesthesized with halothane, 02, and NO2.
Through a midline incision, the aorta and vena cava were exposed
by blunt dissection. After ligation of the tributaries, temporary
clamps were placed on the aorta above the left renal artery,
leaving the circulation of the right renal artery undisturbed.
Through a puncture hole in the aorta, a needle was inserted and
advanced up to the level of the left renal artery. The left renal vein
was punctured to let blood and perfused fluids escape, which were
collected in cotton wool. PBS (37°C, pH 7.3) was infused until the
kidney became pale and no visible blood escaped from the
punctured renal vein. The lysosomal extract containing 40 U of
MPO in PBS was perfused during one minute. After an additional
exposure time of two minutes the kidney was again perfused with
PBS according to Johnson et al [281. Following perfusion the
needle was removed, the aorta was closed with atraumatic sutures,
the clamps were removed and the kidney was allowed to reper-
fuse. Total ischemia time was always less than 12 minutes. Only
rats in which the kidney regained normal perfusion and color were
used for ischemia/reperfusion studies. About five minutes after
reperfusion of the left renal artery, the left renal artery was
clamped for 20 minutes in order to induce ischemia followed by
reperfusion. After surgery the rats were placed under a heat lamp
for two hours and received an injection with buprenorfine (Rec-
kitt and Coleman, UK) s.c. as a pain reliever.
Histological examination
At different time intervals after renal perfusion with the lyso-
somal extract, rats were perfused with PBS at 4°C to remove the
blood from both kidneys, and sacrificed. Specimens from both
kidneys were obtained and prepared for light microscopy, immu-
nofluorescence, and immunohistochemistry. For light microscopy,
renal tissue was fixed in 2% paraformaldehyde/PBS and embed-
ded in plastic. Four micrometer sections were stained with
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Table 1. Antibodies used for immunofluorescence and
immunohistochemistiy on frozen tissues
Antigen
Code recognized Ig(sub-)class Specificity Source
MPO human-MPO poly PMN/monocytes Dakopatts
4.15 human-MPO IgGi PMN/monocytes CLB
ED1 cytoplasmic IgGi PMN [40]
His 48 membrane IgGi neutrophils [41]
R73 TCR IgGi T-cells [42]
1A29 ICAM-1 IgGi Broad Seikagaku
0X42 CD11b IgG2a neutrophils,
monocytes,
NK-cells
Oxford
Sources are: Dakopatts, Glostrup; Denmark; CLB, Central Laboratory
for the Blood Transfusion Service, Amsterdam, The Netherlands; Seika-
gaku, Kogyo, Japan; Oxford, MRC Cellular Immunology Unit, William
Dunn School of Pathology, University of Oxford, England, UK.
hematoxylin-eosin, periodic acid Schiff, or periodic acid silver
methamine. For immunofluorescence (IF) and immunoperoxi-
dase staining (IP), material was snap frozen in freon or iso-
penthane (isobutane), and 2 or 4 jim sections were cut. Sections
were standard fixed with acetone. For detection of MPO, sections
were fixed with acetone-buffered-formalin 9% [29]. After fixation,
sections were incubated with 10% normal rabbit, goat or swine
serum, depending on the conjugate used. Detection of MPO, Ig,
and complement was done by IF using mouse anti-human MPO
(Table 1), rabbit anti-rat IgGIAIM, F(ab')2 goat anti-rat IgG, and
F(ab')2 goat anti-rat C3, respectively (all from Cappel, West
Chester, PA, USA), followed by FITC labeled conjugates. The
following conjugates were used: rabbit anti-mouse FITC (Dako-
patts, Glostrup, Denmark), F(ab')2 goat anti-rabbit FITC, and
F(ab')2 rabbit anti-goat FITC (both from Cappel). Granulocytes,
monocytes, and T cells were detected by IP using the monoclonal
antibodies ED1, His48, and R73, respectively (Table 1), followed
by peroxidase (P0) labeled conjugates. We used rabbit anti-
mouse P0 (Dakopatts) with aminoethylcarbimazole as a sub-
strate. Endogenous peroxidase activity was blocked with 0.05%
H202 in PBS. Sections were counterstained with hematoxylin. All
necessary dilutions were made in PBS pH 7.2. The amount of
MPO, IgG, and complement deposition was estimated on a
semi-quantitative (3+) scale: — absent, weak, + mild, ++
intermediate, + + + strong. To estimate the number of ED1-,
His48- and R73-positive cells, we calculated the average number
of cells per glomerulus by counting all positive cells present within
50 giomeruli and dividing the total number by 50. Interstitial
leukocytes were quantified by using a semi-quantitative method:
— absent, minimal, + mild, + + moderate, and + + + severe.
For immunofluorescence sections were scored in a blinded fash-
ion by two persons.
Expression of adhesion molecules
In an additional set of experiments sequential cryostat sections
were stained for ICAM-1 and CD11b (Table 1). The appropriate
fixation, dilution, and specificity of the MAbs used was tested on
control rat kidney and rat spleen tissues. Briefly, cryostat sections
of snap frozen material, cut 4 jim, were dried for at least 10
minutes and subsequently fixed in acetone. Sections were incu-
bated sequentially with: (a) normal rabbit serum 10% in phos-
phate buffered saline (PBS) for 20 minutes; (b) monoclonal
antibody for 60 minutes; (c) 0.06% H202 in PBS at RT, to block
endogenous peroxidase; (d) rabbit anti-mouse peroxidase labeled
immunoglobulin 1:40, supplemented with 1% rat serum for 60
minutes, followed by aminoethylcarbimazole (AEC) 0.2 mg/mi in
0.05 M acetate buffer pH 4.9, containing 5% dimethylformamide
supplemented with 0.03% hydrogen peroxide or diaminobenzi-
dine (DAB) 0.5 mg/ml plus imidazole 1 mg/mI, in 50 ml PBS
supplemented with 0.03% hydrogen peroxide for 10 minutes.
Sections were counterstained with hematoxylin, mounted in glyc-
erin, and examined. All necessary dilutions were made in PBS.
Appendix and spleen sections served as positive control sections
for ICAM-1 and CD11b. The intensity of staining was scored on
a semi-quantitative scale: — = absent, + = weak, + + = mild,
+ + + = strong, + + + + = very strong. In addition, sections
obtained from kidneys of normal rats (N = 2) were also stained
for ICAM-1 and CD11b.
Plastic sections
To investigate the precise localization of ICAM-1 within gb-
meruli and interstitium renal tissue was also embedded in plastic.
In short, biopsies were fixed in 2% paraformaldehyde in PBS pH
7.4 for one hour at 4°C. After washing overnight in PBS contain-
ing 6% sucrose, the biopsies were dehydrated with 100% acetone
for 30 minutes at 4°C. After dehydration the Ussues were infil-
trated with glycomethacrylate (Technovit 8100 solution A, Kulzer,
GmbH, Wehrheim, Germany) at 4°C for eight hours. Following
infiltration tissues were embedded in a mixture of Technovit
solutions A with an initiator for polymerization (30:1) according
to the manufacturer's recommendation. Polymerization took
place overnight on crushed ice at 4°C. The whole procedure was
done at 4°C and all necessary incubation steps were performed on
a rotor. Two micrometer thick sections were cut on a Reichert
Jung Supercut plastic microtome using tungsten carbide tipped
hard metal knives [30]. Sections were caught on 2% paraformal-
dehyde, affixed on glass slides, and dried.
To study the localization of adhesion molecules sections were
stained using the following method: (a) preincubation with nor-
mal rabbit serum 10% for 30 minutes at 37°C; (b) monoclonal
antibody incubation for two hours at 37°C in the appropriate
dilutions; (c) blocking of the endogenous peroxidase activity when
necessary with hydrogen peroxide 0.06% in PBS at RT; (d)
peroxidase conjugated rabbit anti-mouse 1:40 (Dakopatts) sup-
plemented with 1% normal rat serum for 60 minutes at 37°C; (e)
DAB 0.5 mg/mi in PBS supplemented with imidazole 1 mg/ml plus
0.03% H202 for 10 minutes. Sections were counterstained with
hematoxylin or periodic acid Schiff. The median number of
glomeruli available for counting was 3 and the range varied from
2 to 13 per section.
Statistical analysis
All values were expressed as the mean SuM. Analysis for
statistical differences was done by a nonparametric one way
analysis of variance (ANOVA) for unpaired data. Correlations
within groups for different values were assessed with Spearman's
rank correlation test.
Experimental design
Three groups of experiments were performed according to the
following design:
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Groups
24
hr
MPO
4
days
10
days 24 hr
IgG
4
days
10
days
24
hr
C3
4
days
10
days
I +++ ++ +± +± +± ++± ++± +
II — — — — — — — —
III + — — ++ + + ++ +
Animals were studied in three groups: Group I, MPO immunized and
perfused with the lysosomal extract followed by ischemia/reperfusion (N =
13); Group II, control immunized and perfused with the lysosomal extract
followed by ischemia/reperfusion (N = 6); and Group III, MPO immu-
nized and perfused with the lysosomal extract (N = 6). The amount of
MPO, IgG, and complement deposition was estimated on a semi-quanti-
tative (3+) scale: —, absent; weak; +, mild; ++, intermediate; +++,
strong.
I. Renal perfusion with the lysosomal enzyme extract in MPO-
immunized rats followed by hR. The lysosomal enzyme extract was
perfused into the left kidney in MPO-immunized rats, five weeks
after immunization. After reperfusion the left kidney was clamped
to induce ischemia and reperfused after 20 minutes. Rats were
sacrificed at 24 hours (N = 2), 4 days (N = 7), and 10 days (N =
4) after perfusion.
II. Renal perfusion with the lysosomal enzyme extract in control
immunized rats followed by ER. The same procedure was followed
for control immunized rats as described in I. Rats were sacrificed
at 24 hours (N = 2), 4 days (N = 2), and 10 days (N = 2) after
perfusion.
III. Renal perfusion with the lysosomal enzyme extract in MPO-
immunized rats. The lysosomal enzyme extract was perfused into
the left kidney in MPO-immunized rats, 5 weeks after immuniza-
tion. Rats were sacrificed at 24 hours (N =2), 4 days (N = 2), and
10 days (N = 2) after perfusion.
Results
Humoral immune response to MPO
BN rats immunized with human MPO developed antibodies
reacting with human MPO (Fig. 1). For perfusion studies, rats five
weeks post-immunization were used, that is, at a time when the
humoral response was maximal [22].
Deposition of MPO, IgG, and complement
MPO was detected along the GBM together with IgG and C3 at
24 hours, 4 days, and, weakly, 10 days after perfusion in MPO
immunized rats perfused with the lysosomal extract followed by
hR (group 1) (Table 2). MPO was present in a diffuse granular
pattern (Fig. 2A) whereas IgG and C3 were present in a more
linear pattern. In control immunized rats (group II) MPO could
not be detected along the GBM. MPO was also present along the
GBM for a much shorter period, up to 24 hours, in rats from
group III (MPO immunized and perfused with the lysosomal
extract) as compared to group I rats (MPO immunized rats
perfused with the lysosomal extract followed by I/R) (Table 2).
Despite the short localization of MPO in group III, IgG and C3
stayed along the GBM up to 10 days both in groups I and III
(Fig. 2 B, C). IgG and C3 were present also within vessels and in
Bowman's space (Fig. 2B).
Histopathology
Severe lesions were only found in rats which were immunized
with MPO and perfused with the lysosomal enzyme extract
followed by hR. At 24 hours the main abnormalities detected in
the perfused left kidney consisted of accumulation of eosinophilic
proteinaceous material into the capillary lumen and Bowman's
space, sometimes accompanied by necrosis of the GBM (Fig. 3A).
At 4 and even more at 10 days after perfusion proliferative
changes could be observed within glomeruli and interstitium.
Within glomeruli we found necrosis and wrinkling of the GBM,
intra- and extracapillary proliferation, periglomerular infiltration,
giant cell formation, and breaks in Bowman's capsule (Fig. 3 B,
C). Within the interstitium mononuclear infiltrates were found
surrounding glomeruli, tubuli, and vessels (Fig, 3D). Tubules
showed ischemic changes characterized by eosinophilic necrosis
and desquamation of tubular epithelial cells. Within the tubular
lumina eosinophilic and sometimes cellular casts were found. In
some animals vessels were observed with hyalinized walls sur-
rounded by mononuclear cells (Fig. 3 C, D). Within group II rats
(control immunized and perfused with the lysosomal extract
followed by I/R) we observed deposition of eosinophilic material
within the glomeruli at 24 hours after perfusion. Tubules showed
ischemic changes at 4 and 10 days after perfusion. In addition
slight interstitial infiltrate was present. However, proliferative
changes were not observed. Also, in group III rats (MPO immu-
nized and perfused with the lysosomal extract) no significant
lesions were observed, except for a transient cell influx at 24 hours
and a slight interstitial infiltrate.
Immunophenotyping
In accordance with the findings by light microscopic examina-
tion, immunophenotyping of renal tissue from group I rats showed
larger numbers of intraglomerular, endo- and extracapillary mac-
rophages and PMN at days 4 and 10 after perfusion (Table 3 and
Fig. 3 F, H). T cells were observed in small numbers within the
glomeruli and more abundantly within the interstitium at day 10
(Table 3). A transient glomerular neutrophil and monocyte influx
was found at 24 hours in MPO immunized rats perfused with the
Table 2. Intraglomerular deposition of MPO, IgG, and C3 along the
GBM in rats sacrificed 24 hours, 4 days, and 10 days after perfusion
S
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Fig. 1. Anti-MPO antibody titers in control (Ctrl) (N = 6) and MPO
immunized (N = 10) rats. Antibodies to human MPO were measured by
ELISA at 5 weeks after immunization. Results are expressed as arbitrary
units.
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Fig. 2. Localization of MPO, lgG, and complement by immunofluoresence.
A, B, and C are photographs from BN rats perfused with the lysosomal
extract followed by ischemia/reperfusion injury (group I). (A) Diffuse
granular deposits of MPO along the GBM in a rat sacrificed at 24 hours
after perfusion (X320). (B) Granular IgG deposits in a rat sacrificed at 10
days after perfusion (X320). (C) Granular deposits of complement along
the GBM at day 10 after perfusion (X320).
lysosomal extract (Group III). Within the interstitium mild infil-
tration of inflammatory cells was seen in groups II and III at 24
hours and 4 days after perfusion.
Up-regulation of adhesion molecules
The intensity of ICAM-1 staining was strong and diffusely
present, with staining of all glomerular cells, in group I (MPO
immunized and perfused with the lysosomal extract followed by
IIR) and group III rats (MPO immunized and perfused with the
lysosomal extract). The high intensity of ICAM-1 staining in those
groups differed significantly (P < 0.008) from the mild and diffuse
staining as found in group II (control immunized and perfused
with the lysosomal extract followed by fIR; Fig. 3 E, G; Table 4).
However, compared to normal control rats in which glomerular
ICAM-1 staining was absent or only weakly present (data not
shown), ICAM-1 was also up-regulated in group II. Proximal
tubular epithelial cells were positive for ICAM-l in groups I and
III, but not in group II. Interstitial infiltrates, as present in group
I, were weakly IcAM-1 positive. Cells positive for CDIIb, a
ligand of ICAM-1, were most abundantly found in group I (MPO
immunized and perfused with the lysosomal extract followed by
I/R) and not in group II (control immunized and perfused with
lysosomal extract followed by I/R). The amount of infiltrated
CD11b positive cells in groups I and III differed significantly from
that of group II (P < 0.00 1). Intraglomerular ICAM- I expression
tended to correlate with the infiltration of CD11b positive cells (r
= 0.374, P < 0.1).
Discussion
In the present study we investigated the contribution of renal
ischemia to the induction of anti-myeloperoxidase (MPO) associ-
ated necrotizing crescentic glomerulonephritis. In a previous
study we described that the development of NCGN in the rat is
dependent on the presence of an anti-MPO immune response and
the localization of a lysosomal extract containing lytic enzymes
and MPO in combination with hydrogen peroxide (H202) along
the glomerular basement membrane (GBM) [22}. It was postu-
lated that the immune deposits initially present were rapidly
cleared by the active proteolytic enzymes together with reactive
oxygen species, resulting in the pauci-immune character of the
lesions [22]. In the present study rats were immunized with MPG
and perfused with the lysosomal extract only. It proved that
perfusion of hydrogen peroxide (H202) could be replaced by
ischemialreperfusion (I/R) injury in producing the aforemen-
tioned lesions although immune deposits were detectable for a
longer period compared to the previous study [22]. The findings
suggest that hR injury, which activates endothelial cells and bind
neutrophils possibly by the production of oxygen metabolites [14,
31], contributes to the development of lesions in NCGN.
To study the effect of renal ischemia in this model three
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Fig. 3. A, B, C, and D. Light microscopy of lesions found in MPO-immunized rats perJbsed with the lysosomal extract followed by ischemia reperfusion injuiy(group I). Sections were stained with either hematoxylin (HE) or methamine-silver (MS) with aniline red counterstaining. (A) Capillaries occluded with
eosinophilic material and erythrocytes and tuft necrosis at 24 hours after perfusion (MS, X560) (B), (C), and (D) Intra- and extracapillary cell
proliferation, crescent formation and periglomerular and perivascular infiltration of inflammatoiy cells, tubular necrosis and interstitial infiltration of
inflammatory cells at 10 days after perfusion (MS and HE, X225). E, F, G, and H. Light microscopy of sections stained, by immunohistochemistry, with
ED1, a monocyte marker, and ICAM-1, a cell adhesion molecule in MPO-immunized rats perfused with the lysosomal extract followed by ischemia
reperfusion injury (group I). Sections were counterstained with hematoxylin. (E) Diffuse staining of ICAM-1 within glomeruli and Bowman's capsule
in a rat sacrificed at 4 days after perfusion (X560). (F) Intracapillary infiltration of monocytes in a rat sacrificed at 4 days after perfusion (ED-i, x560).
(G) Diffuse staining of ICAM-1 within glomeruli and on vessel walls in the interstitium in a rat sacrificed at 10 days after perfusion (X225). (H) Intra-
and extracapillary as well as periglomerular and peritubular infiltration of monocytes in a rat sacrificed at 10 days after perfusion (ED-i, x225).
Table 3. Intraglomerular and interstitial presence of neutrophils, macrophages, and T cells, as detected by the mAb's ED1, His 48, and R73,
respectively (see Table 1)
Infiltrating cells
PMN
Groups
1
Intraglomerular cellsa Interstitial cells'
24 hr
2.6 0.5
4 days 10 days 24 hr 4 days 10 days
3.1 1.5 1.6 0.5 + ++ ++
II 0.7 0.1 0.8 0.2 0.5 0.4 —
III 1.7 0.1 0.6 0.1 0.5 0.1 ++ — —
Mø 1
H
III
2.8± 1.1
0.3 0.2
1.5 0.3
3.2± 1.0
0.3 0.0
1.4 0.1
7.1± 4.3
0.6 0.3
0.3 0.0
++±
—
+
++++
T cells 1
II
III
0
0
0
0.1 0.1
0
0
0.5 0.7
0
0
—
—
—
+±
—
—
++
—
Rats were sacrificed at 24 hours, 4 and 10 days after perfusion. The three groups included: Group I, MPO immunized and perfused with the lysosomal
extract followed by ischemia/reperfusion (N = 13); Group II, control immunized and perfused with lysosomal extract followed by ischemia/reperfusion(N = 6); and Group III, MPO immunized and perfused with the lysosomal extract (N = 6). Numbers represent mean SEM.
For estimation of the number of PMN, monocytes and T cells, we calculated the mean number of cells per glomerulus by counting all positive cells
present within 50 glomeruli and dividing the total number by 50
Labeled interstitial leukocytes were quantified by using a semiquantitative method: — absent, minimal, + mild, + + moderate, and + + + severe
Table 4. Up-regulation of IcAM-1 and influx of CD11b positive cells
in rats sacrificed 24 hours, 4 days, and 10 days after perfusion
IAM-1 CDIIb
Groups 24 hr 4 days 10 days 24 hr 4 days 10_days
I +++ ++± +++ 3.1 1.7±0.8 3.3±2.2
II +± ++ +± 0.1 0.1 0.5 0.0 0.1 0.0
III +++± +++ ++± 0.9 0.0 0.5 0.0 0.4 0.4
Animals were divided into: Group I, MPO immunized and perfused
with the lysosomal extract followed by ischemia/reperfusion (N = 13);
Group II, control immunized and perfused with the lysosomal extract
followed by ischemia/reperfusion (N = 6); Group Ill, MPO immunized
and perfused with the lysosomal extract (N = 7). The amount of ICAM-1
was estimated on a semi-quantitative (4+) scale: —,absent; +, weak; ++,
mild; + + +, strong; + + + +,very strong. For estimation of the number of
CD11b positive cells, we calculated the mean number of cells per
glomerulus by counting all positive cells present within 50 glomeruli and
dividing the total number by 50. Numbers represent mean SEM.
experimental groups were formed: group I in which MPO immu-
nized rats were perfused with the lysosomal extract followed by
I/R, group II in which control immunized rats were perfused with
the lysosomal extract followed by I/R, and group III in which
MPO immunized rats were perfused with the lysosornal extract
only. All rats immunized with MPO developed an anti-MPO
response. We chose to clamp the kidney after perfusion and
subsequent recovery because clamping before perfusion would
result in a poor circulation and distribution of the MPO.
MPO localized along the GBM in a granular pattern, as
detected at 24 hours after perfusion in groups I and III rats that
were MPO immunized. In group II, the control immunized rats,
no deposition of MPO was observed. Interestingly, MPO re-
mained present along the GBM up to 10 days in group I in
contrast to group III. In a previous study in which MPO immu-
nized rats were perfused with the lysosomal extract and H202,
MPO was present for a shorter period of time along the GBM
[22]. The prolonged localization of MPO in group I rats might be
related to the fact that the renal artery was clamped soon after
perfusion with the lysosomal extract in group I and not in group
III. The exact mechanisms underlying removal or persistence of
MPO are at present not clear. In contrast to the short presence of
MPO in group III, IgG and C3 stayed along the GBM up to 10
days after perfusion in both groups I and III, The far longer
presence of the antibody in comparison to the antigen, MPO in
the present model, has also been reported in other studies in
which cationized IgG served as an antigen [32, 33]. The rapid
clearance of the antigen from the GBM might be due to its faster
removal or masking of the antigen by the antibody [32]. In a
previous study in which we perfused the lysosomal extract in
combination with H202, we observed fast removal of IgG after 24
hours [22], in contrast to the present study in which IgG persisted
along the GBM up to 10 days. A possible explanation might be the
longer presence of MPO in the present study or the more effective
degradation of lgG in the previous study due to the presence of
higher concentrations of H202 along the GBM as well as higher
numbers of toxic monocytes [22]. In our previously described
model [22] in situ immune complex formation, resulting from
binding of anti-MPO to MPO localized to the GBM, played an
essential role in the initial phase of the lesions. However, immune
complexes were rapidly cleared from the lesions. In accordance,
Germuth et al [9] postulated that in human pauci-immune NCGN
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immune deposits are also initially present but rapidly cleared.
Various factors may be involved in the rapid clearance of immune
deposits as mentioned before. Lytic enzymes and reactive oxygen
species derived from activated neutrophils and monocytes/macro-
phages appear to be involved. In this respect, the neutrophil
activating capacity of anti-MPO [34, 35] is of interest. Primed
neutrophils express their granule constituents, such as MPO and
proteinase 3, at their cell membrane [36]. Antibodies to these
constituents can bind to their exposed antigens resulting in
degranulation and the production of reactive oxygen species [34,
351. Immunization of rats with human MPO results in the
generation of antibodies that cross react to a variable extent with
rat MPO (unpublished observation). The extent of cross reactivity
may be related to the neutrophil activating capacity of the
antibodies and, as such, to the extent of persistence of immune
deposits in the lesions. In this respect it is noteworthy that Yang,
Jennette and Falk [1 could not reproduce the pauci-immune
character of the lesions in a nearly identical rat model of
anti-MPO associated NCGN. Further studies directed, among
others, at the induction of autoantibodies to rat MPO, should
elucidate the factors that are precisely involved in the clearance of
immune deposits to better understand human anti-MPO associ-
ated pauci-immune NCGN.
By immunohistology the most severe lesions were observed in
group I rats. At 24 hours the main abnormalities consisted of
intracapillary accumulation of eosinophilic proteinaceous mate-
rial. At 4 days and even more pronouncedly at 10 days, prolifer-
ative changes such as ultra- and extracapillary cell proliferation,
periglomerular infiltration, and ruptures of Bowman's capsule
could be observed. Within the interstitium tubuli showing isch-
emic changes were surrounded by a mononuclear infiltrate. Rats
from group H only showed slight ischemic changes and some
interstitial infiltration of mononuclear cells, demonstrating that
hR injury in itself did not induce those lesions. In group III a
transient influx of neutrophils and monocytes was observed. The
transient presence of inflammatory cells, in contrast to the
persistence of IgG and C3, in group III has also been observed in
other models of in situ immune complex formation [38, 39].
In the present study we found that renal hR injury in MPO
immunized rats perfused with lysosomal extract contributes to the
development of proliferative necrotizing glomerulonephritis. hR
injury alone (group II) resulted in minor lesions only. The
mechanisms underlying the contribution of ItR to the pathogen-
esis of anti-MPO associated NCGN might be several-fold. It has
been shown that MPO immunized rats perfused with hydrogen
peroxide, an oxygen metahohite, in addition to a lysosomal extract
developed severe proliferative NCGN [22]. The present findings
suggest that renal ischemia induces endothehial cells to produce
H202 and, as such, provide the substrate for MPO. The prolonged
presence of MPO, as well as IgG and complement, observed after
the induction of hR in MPO immunized rats perfused with the
lysosomal extract, might also have influenced the effector phase of
NCGN by prolonged attraction of neutrophils and monocytes and
by prolonged production of toxic oxygen metabolites. Otherwise,
hR might have induced up-regulation of adhesion molecules
important for binding, activation, and migration of inflammatory
cells. In the present study we observed that renal hR leads to
increased expression of ICAM-1 as compared to renal sections
from normal rats. This did not, however, not result in an influx of
CD1 lb-positive inflammatory cells. Perfusion of lysosomal extract
in MPO immunized rats also resulted in a strong increase in
ICAM-1 expression, but was in itself not sufficient to induce influx
of inflammatory cells. Generally, a weak association was observed
between intraglomerular expression of ICAM-1 and the presence
of cells positive for CD11b (ligand of ICAM-1). Apparently,
activation of inflammatory cells with up-regulation of their adhe-
sion molecules is another prerequisite for their influx into the
renal tissue. Models of lung injury induced by hind limb hR injury
have demonstrated the important contribution of elevated levels
of cytokines like IL-i and TNF in this respect [17, 21]. These
factors might therefore have played an important role in our
model by activation of both endothelial cells and PMN, and need
further investigation.
In conclusion, hR injury contributes to the development of
anti-MPO associated NCGN. These data are relevant in view of
the initial histopathological lesions of ANCA associated NCGN
and the occurrence of this disease particularly in elderly patients.
The exact mechanisms involved need further investigation.
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